Network
Hypo-RESOLVE unites leading healthcare players as well as patient organisations from all over Europe and the United States
Home
  • The project
    • Funders
    • Governance
    • Interviews
    • Work Packages
  • Concept & Approach
  • Network
    • Advisors
  • People with Diabetes
  • News & Events
  • Publications
  • Academic Partners
    • Stichting Radboud universitair medisch centrum RADBOUDUMC
    • King's College London KCL
    • Medizinische Universität Graz MUG
    • University of Cambridge UCAM
    • Centre Hospitalier Universitaire de Montpellier CHUM
    • University of Southern Denmark SDU
    • University of Lausanne UNIL
    • University of Sheffield USFD
    • Nordsjællands University Hospital Hillerød NOH
    • University of Dundee, School of Medicine UNIVDUN
    • European Research and Project Office GmbH Eurice
    • Swiss Institute of Bioinformatics SIB
    • Università degli Studi di Padova UNIPD
    • University of Edinburgh UEDIN
  • Industry Partners
    • Novo Nordisk A/S NN
    • Eli Lilly and Company Limited Lilly
    • Sanofi-Aventis Deutschland GmbH 
    • Abbott, Diabetes Care Abbott
    • Medtronic
  • Associated Partners
    • JDRF
    • International Diabetes Federation IDF
    • T1D Exchange
    • The Leona M. and Harry B. Helmsley Charitable Trust HCT
  • Intranet
  • Imprint
  • Privacy
  • Contact
EU logo
IMI logo
EFPIA logo
T1D logo
JDRF logo
IDF logo
Helmsley logo

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 777460. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and T1D Exchange, JDRF, International Diabetes Federation (IDF), The Leona M. and Harry B. Helmsley Charitable Trust.